The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2025 | Replacing standard FISH panels with WGS in multiple myeloma
Francesco Maura, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the need to replace standard fluorescence in situ hybridization (FISH) panels with whole-genome sequencing (WGS) in clinical practice to improve the diagnosis and classification of multiple myeloma (MM). Dr Maura argues that WGS is the future of genetic testing and highlights the need for improvements in infrastructure to enable widespread availability of this technique. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
